ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma (NGR010)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00484276
Recruitment Status : Completed
First Posted : June 8, 2007
Last Update Posted : October 1, 2018
Sponsor:
Information provided by (Responsible Party):
MolMed S.p.A.